We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00645164
First Posted: March 27, 2008
Last Update Posted: June 8, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Healthpoint
  Purpose
The product is being tested to see if exposure to light causes photoallergic reactions on the skin.

Condition Intervention Phase
Healthy Other: Ointment Vehicle Drug: Xenaderm Phase 1

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Official Title: Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment

Further study details as provided by Healthpoint:

Primary Outcome Measures:
  • Frequency Distribution of Skin Irritation Scores [ Time Frame: 48-hours post irradiation ]
    Scores based on skin irritation scale of 0 (no reaction) to 7 (large vesiculo-bullous reaction) in whole units. Photoallergic reactions were characterized by irritation scores of 3 or higher.


Enrollment: 59
Study Start Date: March 2008
Study Completion Date: June 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Xenaderm
Subject serves as own control
Other: Ointment Vehicle
Subject acts as own control. 20 mg under Finn chambers
Drug: Xenaderm
20 mg under Finn chambers

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy subjects

Exclusion Criteria:

  • Less than 18 years
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00645164


Locations
United States, North Carolina
Suncare Research Laboratories
Winston-Salem, North Carolina, United States
Sponsors and Collaborators
Healthpoint
Investigators
Principal Investigator: Joe Stanfield, PhD Suncare Research Laboratories
  More Information

Responsible Party: H. B. Slade, MD, Healthpoint
ClinicalTrials.gov Identifier: NCT00645164     History of Changes
Other Study ID Numbers: 011 101 09 002
First Submitted: March 24, 2008
First Posted: March 27, 2008
Results First Submitted: October 8, 2008
Results First Posted: April 6, 2009
Last Update Posted: June 8, 2010
Last Verified: June 2010

Keywords provided by Healthpoint:
wound healing
photoallergenicity
Healthy subjects

Additional relevant MeSH terms:
Dermatitis, Photoallergic
Dermatitis, Allergic Contact
Dermatitis, Contact
Dermatitis
Skin Diseases
Photosensitivity Disorders
Skin Diseases, Eczematous
Hypersensitivity, Delayed
Hypersensitivity
Immune System Diseases
Castor Oil
Cathartics
Gastrointestinal Agents